Maynard Um
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Disc Medicine (IRON)
-
-
-
-
-
-
-
Disc Medicine launches expanded access program for bitopertin
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Disc Medicine (IRON)
-
-
-
-
-
-
-
Jefferies Defends Disc Medicine (IRON): 'Overreaction to Article on IRON EPP Approvability Under CNPV'
-
-
-
-
-
-
-
Raymond James on Disc Medicine (IRON): 'we believe DISC-0974 peak sales could approach ~$1B+ in MF alone'
-
-
-
-
-
-
-
Disc Medicine (IRON) PT Raised to $100 at Leerink Partners, 'one of our Top Picks for 2025'
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Disc Medicine (IRON)
-
468,761 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


